How the Mammalian Cell Fermentation Technology Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of theMammalian Cell Fermentation Technology Market?
As the demand for biologics rises, so is the expectation for the mammalian cell fermentation technology market to experience growth. Biologics, medical products originated from living tissues or their parts, have shown efficacy in addressing diseases such as cancer, autoimmune ailments, and infections. The surge in demand is instigated by improvements in biotechnology, its proficiency in managing widespread chronic diseases like cancer and autoimmune disorders, regulatory green lights, and increased R&D investments. Mammalian cell fermentation technology is adept at generating complex biologics, answering to the rising requisition for personalized, targeted treatments. Its scalability, flexibility, and the capacity to create premium proteins propels biopharmaceutical industry innovation. For example, according to the US-based National Library of Medicine, in February 2024, the FDA sanctioned 55 new drugs in 2023, comprising 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), which is a 50% rise vis-a-vis the approval of 37 in 2022. Thus, the escalating demand for biologics propels the growth of the bacterial cell fermentation technology market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp
#What Long-Term Growth Rate is Expected for theMammalian Cell Fermentation Technology Market Between 2025 and 2034?
In the past few years, the mammalian cell fermentation technology market has seen swift growth. Expected to rise from $51.29 billion in 2024, it is predicted to reach $57.48 billion in 2025 with a compound annual growth rate (CAGR) of 12.1%. The growth noticed during the historical period can be connected with a surge in demand for biologics and biosimilars, a heightened focus on personalized medicine, a proliferation in biopharmaceutical output, and rising demand for scalable and efficient cell culture procedures.
The market for mammalian cell fermentation technology is predicted to experience swift expansion in the coming years, escalating to a value of $89.54 billion by 2029, which signifies a compound annual growth rate (CAGR) of 11.7%. Multiple factors contribute to this predicted growth during the forecast period, including a heightened prevalence of chronic diseases, an influx of investments from multinational companies, increased application of sophisticated bioprocessing methodologies, augmented spending on the research and development of innovative recombinant proteins, and a rising demand for cancer treatments. In the forecast period, key trends to watch include technological improvements in cell culture and bioreactor design, the development of next-generation bioprocessing technologies, incorporation of multi-omics strategies, and the rise of technology-led automation.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16473
Which Cutting-Edge Market Trends Are Expected to Drive theMammalian Cell Fermentation Technology Market’s Growth?
Leading businesses in the mammalian cell fermentation technology industry are concentrating their efforts on the creation of innovative technologies like mammalian cell culture to fortify their market standing. The mammalian cell culture stands as a vital instrument in multiple sectors, such as biomanufacturing, research, and regenerative medicine, facilitating the manufacture of therapeutic proteins, vaccines, and functional cells or tissue replicas. To exemplify, Syntegon, a German biotechnology corporation, introduced its unique Modular Bioprocessing Platform (MBP) at Achema 2024 in June 2024. This revolutionary platform aims to address the primary difficulties in biopharmaceutical manufacturing. It offers a highly versatile, completely integrated, automated solution apt for numerous uses, including microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The MBP’s modular composition accommodates shorter lead times and lessens expenses without compromising functionality and quality, adhering to the “made in Germany” standard. Its pre-built cleanroom configuration situates all ancillary technology outside the cleanroom, augmenting efficiency and streamlining maintenance.
What Are the Leading Market Players Impacting theMammalian Cell Fermentation Technology Market’s Growth Trend?
Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Mammalian Cell Fermentation Technology Market Driving Opportunities and Innovations?
The mammalian cell fermentation technology market covered in this report is segmented –
1) By Type: Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types
2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications
3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=16473&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theMammalian Cell Fermentation Technology Market?# Market Expansion?
North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Mammalian Cell Fermentation Technology Market 2025, By The Business Research Company:
Cell and Gene Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
Stem Cell Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report
Cell Culture Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
